These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31657548)

  • 1.
    Santini BL; Zúñiga-Bustos M; Vidal-Limon A; Alderete JB; Águila SA; Jiménez VA
    J Chem Inf Model; 2020 Feb; 60(2):786-793. PubMed ID: 31657548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular Dynamics Simulation Analysis of Anti-MUC1 Aptamer and Mucin 1 Peptide Binding.
    Rhinehardt KL; Srinivas G; Mohan RV
    J Phys Chem B; 2015 Jun; 119(22):6571-83. PubMed ID: 25963836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel aptamer-nanoparticle bioconjugates enhances delivery of anticancer drug to MUC1-positive cancer cells in vitro.
    Yu C; Hu Y; Duan J; Yuan W; Wang C; Xu H; Yang XD
    PLoS One; 2011; 6(9):e24077. PubMed ID: 21912664
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-MUC1 aptamer: A potential opportunity for cancer treatment.
    Nabavinia MS; Gholoobi A; Charbgoo F; Nabavinia M; Ramezani M; Abnous K
    Med Res Rev; 2017 Nov; 37(6):1518-1539. PubMed ID: 28759115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A dual-targeting DNA tetrahedron nanocarrier for breast cancer cell imaging and drug delivery.
    Liu X; Wu L; Wang L; Jiang W
    Talanta; 2018 Mar; 179():356-363. PubMed ID: 29310244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific targeting delivery to MUC1 overexpressing tumors by albumin-chitosan nanoparticles conjugated to DNA aptamer.
    Esfandyari-Manesh M; Mohammadi A; Atyabi F; Nabavi SM; Ebrahimi SM; Shahmoradi E; Varnamkhasti BS; Ghahremani MH; Dinarvand R
    Int J Pharm; 2016 Dec; 515(1-2):607-615. PubMed ID: 27989825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel MUC1 aptamer-modified PLGA-epirubicin-PβAE-antimir-21 nanocomplex platform for targeted co-delivery of anticancer agents in vitro and in vivo.
    Bahreyni A; Alibolandi M; Ramezani M; Sarafan Sadeghi A; Abnous K; Taghdisi SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():231-238. PubMed ID: 30537619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamer-guided DNA tetrahedron as a novel targeted drug delivery system for MUC1-expressing breast cancer cells in vitro.
    Dai B; Hu Y; Duan J; Yang XD
    Oncotarget; 2016 Jun; 7(25):38257-38269. PubMed ID: 27203221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MUC1 Aptamer as Carrier Tool of the Potential Radiosensitizer 1,10 Phenanthroline in MCF-7 Breast Cancer Cells.
    Alves LN; Missailidis S; Lage CAS; DE Almeida CEB
    Anticancer Res; 2019 Apr; 39(4):1859-1867. PubMed ID: 30952726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA aptamers against the MUC1 tumour marker: design of aptamer-antibody sandwich ELISA for the early diagnosis of epithelial tumours.
    Ferreira CS; Papamichael K; Guilbault G; Schwarzacher T; Gariepy J; Missailidis S
    Anal Bioanal Chem; 2008 Feb; 390(4):1039-50. PubMed ID: 17694298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MUC1 aptamer conjugated to chitosan nanoparticles, an efficient targeted carrier designed for anticancer SN38 delivery.
    Sayari E; Dinarvand M; Amini M; Azhdarzadeh M; Mollarazi E; Ghasemi Z; Atyabi F
    Int J Pharm; 2014 Oct; 473(1-2):304-15. PubMed ID: 24905777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational design of single-stranded DNA hairpin aptamers immobilized on a biosensor substrate.
    Jeddi I; Saiz L
    Sci Rep; 2021 May; 11(1):10984. PubMed ID: 34040012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers.
    Ferreira CS; Matthews CS; Missailidis S
    Tumour Biol; 2006; 27(6):289-301. PubMed ID: 17033199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrochemiluminescent detection of mucin 1 protein and MCF-7 cancer cells based on the resonance energy transfer.
    Wei W; Li DF; Pan XH; Liu SQ
    Analyst; 2012 May; 137(9):2101-6. PubMed ID: 22421993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Solution structure of a truncated anti-MUC1 DNA aptamer determined by mesoscale modeling and NMR.
    Baouendi M; Cognet JA; Ferreira CS; Missailidis S; Coutant J; Piotto M; Hantz E; Hervé du Penhoat C
    FEBS J; 2012 Feb; 279(3):479-90. PubMed ID: 22129448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MUC1 Aptamer/Negatively Charged Amino Acid Dendrimer Conjugates for Targeted Delivery to Human Lung Adenocarcinoma A549 Cells.
    Masuda M; Kawakami S; Wijagkanalan W; Suga T; Fuchigami Y; Yamashita F; Hashida M
    Biol Pharm Bull; 2016; 39(10):1734-1738. PubMed ID: 27725454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel aptamer functionalized CuInS2 quantum dots probe for daunorubicin sensing and near infrared imaging of prostate cancer cells.
    Lin Z; Ma Q; Fei X; Zhang H; Su X
    Anal Chim Acta; 2014 Mar; 818():54-60. PubMed ID: 24626403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MUC1 as a potential target in anticancer therapies.
    Pillai K; Pourgholami MH; Chua TC; Morris DL
    Am J Clin Oncol; 2015 Feb; 38(1):108-18. PubMed ID: 23608828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aptamer-based detection of epithelial tumor marker mucin 1 with quantum dot-based fluorescence readout.
    Cheng AK; Su H; Wang YA; Yu HZ
    Anal Chem; 2009 Aug; 81(15):6130-9. PubMed ID: 19572710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impedimetric aptamer based determination of the tumor marker MUC1 by using electrospun core-shell nanofibers.
    Paimard G; Shahlaei M; Moradipour P; Karamali V; Arkan E
    Mikrochim Acta; 2019 Dec; 187(1):5. PubMed ID: 31797120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.